Brewin Dolphin LTD Organon & Co. Transaction History
Brewin Dolphin LTD
- $2.08 Billion
- Q2 2022
A detailed history of Brewin Dolphin LTD transactions in Organon & Co. stock. As of the latest transaction made, Brewin Dolphin LTD holds 1,327 shares of OGN stock, worth $12,009. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,327
Previous 1,327
-0.0%
Holding current value
$12,009
Previous $46,000
2.17%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding OGN
# of Institutions
792Shares Held
210MCall Options Held
2.71MPut Options Held
1.79M-
Black Rock Inc. New York, NY32.6MShares$295 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$292 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.2MShares$92.6 Million0.03% of portfolio
-
State Street Corp Boston, MA9.52MShares$86.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.09MShares$82.3 Million0.05% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $2.3B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...